雅思阅读模拟真题系列01,曼拓教育微信公众号文章

很多同学都会觉得已经把剑桥的阅读练习做了很多遍，答案都可以背下来了，所以在这里为大家提供系列阅读模拟题，希望可以为各位考生带来做题的新鲜感，进一步提升自己做题的技巧。

曼拓君

雅思阅读模拟真题：Why did a promising heart drug fail

本系列的模拟试题在难度、长度、题材、题型方面都与雅思考试近似的练习。这些练习，均以国外报刊上的文章为素材，按雅思阅读的题型，出题并提供答案及简单注释。欢迎大家积极使用。

Why did a promising heart drug fail?

Doomed drug highlights complications of meddling with cholesterol.

1. The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of 'good' cholesterol are still one of the most promising means to combat spiralling heart disease.

2. Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib, a drug designed to raise heart-protective high-density lipoproteins (HDLs). In a trial of 15000 patients, a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone.

3. The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. "There have been no red flags to my knowledge," says John Chapman, a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. "This cancellation came as a complete shock."

4. Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically, torcetrapib blocks a protein called cholesterol ester transfer protein (CETP), which normally transfers the cholesterol from high-density lipoproteins to low density, plaque-promoting ones. Statins, in contrast, mainly work by lowering the 'bad' low-density lipoproteins.

Under pressure

5. Researchers are now trying to work out why and how the drug backfired, something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation, it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall.

6. But it is also possible that the whole idea of blocking CETP is flawed, says MotiKashyap, who directs atherosclerosis research at the VA Medical Center in Long Beach, California. When HDLs excrete cholesterol in the liver, they actually rely on LDLs for part of this process. So inhibiting CETP, which prevents the transfer of cholesterol from HDL to LDL, might actually cause an abnormal and irreversible accumulation of cholesterol in the body. "You're blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway," says Kashyap.

Going up

7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug, called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. "The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL," says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore.

(613 words nature)

文字编辑时，点击左侧模板/图片，就可以插入到文字中间。

Questions 1-7　　

This passage has 7 paragraphs 1-7.Choose the correct heading for each paragraph from the list of headings below.

Write the correct number i-ix in boxes 1-7 on your answer sheet.

List of Headings

i. How does torcetrapib work?

ii. Contradictory result prior to the current trial

iii. One failure may possibly bring about future success

iv. The failure does not lead to total loss of confidence

v. It is the right route to follow

vi. Why it is stopped

vii. They may combine and theoretically produce ideal result

viii. Whatis wrong with the drug

ix. It might be wrong at the first place

Example answer

Paragraph 1 iv

1. Paragraph 2

2. Paragraph 3

3. Paragraph 4

4. Paragraph 5

5. Paragraph 6

6. Paragraph 7

Questions 7-13　　

Match torcetrapib，HDLs，statin and CETP with their functions (Questions 8-13).

Write the correct letter A, B, C or D in boxes 8-13 on your answer sheet.

NB You may use any letter more than once.

1. It has been administered to over 10,000 subjects in a clinical trial.

2. It could help rid human body of cholesterol.

3. Researchers are yet to find more about it.

4. It was used to reduce the level of cholesterol.

5. According to Kashyap, it might lead to unwanted result if it is blocked.

6. It produced contradictory results in different trials.

7. It could inhibit LDLs.

List of choices

A. Torcetrapic

B. HDLS

C. Statin

D. CETP

Suggested Answers and Explanations

1. vi

2. ii

3. vii 本段介绍了torcetrapib和statin的治病原理，但是同时短语“in contrast”与之前第二段后半段的内容呼应，暗示了这两种药在理论上能相辅相成，是理想的搭配。第一个选项无法涵盖整段意义，故选择i是错误的。

4. iii 本段分析了可能导致torcetrapibl临床试验失败的原因，后半段指出如果以上推测正确，那么未来的药物可借鉴这个试验，设法避免torcetrapib的缺陷，研制出有效的药物。viii选项无法涵盖后半段的意思。

5. ix 见首句。

6. v

7. A 见第二段。题目中administer一词意为“用药”，subject一词为“实验对象”之意。

8. B 见第四段“… to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body.”即HDLs的作用最终是将choleserol清除出人体：“… for removal from the body”。

9. B 见第四段“But HDLs are complex and not entirely understood.”

10. C 见第二段“… plus a cholesterol-lowering statin”，即statin是可以降低cholesterol的。

11. D 见第六段“So inhibiting CETP, … might actually cause an abnormal and irreversible accumulation of cholesterol in the body.

12. A 见第三段。

13. C 见第四段“Statins, in contrast, mainly work by lowering the 'bad' low-density lipoproteins.”

雅思四项精品7分班
课程简介	为短期冲刺突破雅思瓶颈而生。课程将精密解析雅思写作辩证逻辑结构搭建，迅速掌握解题技巧、审题扣题、解题思路和辩证分析、开头结尾写作技法；听力快速准确抓住出题命脉；阅读多类型练习加分析；口语实景演练模拟，口语老师根据你自身情况为你指点迷津。不论六分还是七分，我们都有专业全面的专项课程安排计划。
开班时间	白班（11月7日）：每周一至五 10:00-12:00 晚班（11月7日）：每周一至五 18:00-20:00 周末班（11月5日）：每周六、日 10:00-12:00 13:30-15:30
课程周期	28小时，三周结课
价格	$360